Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $5.68 Analyst target: $11.00 Upside: 93.66%
Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy. The company is headquartered in Eden Prairie, Minnesota.
See the full interactive analysis & chart →Informational only — not investment advice.